Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2. (Q45338163)

13 December 2017

Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2. (English)

1 reference

13 December 2017

Annette Kopp-Schneider

4

1 reference

13 December 2017

Markus Schmitt

2

0 references

author name string

Hanna Seitz

1

1 reference

13 December 2017

Gerd Böhmer

3

1 reference

13 December 2017

Martin Müller

5

1 reference

13 December 2017

language of work or name

English

0 references

publication date

3 October 2012

1 reference

International Journal of Cancer

13 December 2017

1 reference

13 December 2017

132

1 reference

13 December 2017

E139-48

1 reference

13 December 2017

3

1 reference

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

13 December 2017

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

Vaccines to prevent infections by oncoviruses

21 January 2018

1 reference

HPV vaccines: preclinical development

21 January 2018

1 reference

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

21 January 2018

1 reference

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types

21 January 2018

1 reference

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

21 January 2018

1 reference

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

21 January 2018

1 reference

Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.

21 January 2018

1 reference

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region

21 January 2018

1 reference

Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin

21 January 2018

1 reference

A protective and broadly cross-neutralizing epitope of human papillomavirus L2.

21 January 2018

1 reference

Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes

21 January 2018

1 reference

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies

21 January 2018

1 reference

Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study

21 January 2018

1 reference

Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers

21 January 2018

1 reference

Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay

21 January 2018

1 reference

Bead-based multiplex genotyping of human papillomaviruses

21 January 2018

1 reference

High-throughput detection and multiplex identification of cell contaminations

21 January 2018

1 reference

Clustal W and Clustal X version 2.0

21 January 2018

1 reference

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

21 January 2018

1 reference

Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions

21 January 2018

1 reference

Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67

21 January 2018

1 reference

Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97.

21 January 2018

1 reference

Whole-genome sequence analysis of human papillomavirus type 18 from infected Thai women

21 January 2018

1 reference

Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions

21 January 2018

1 reference

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

21 January 2018

1 reference

Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines

21 January 2018

1 reference

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2

21 January 2018

1 reference

Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies

21 January 2018

1 reference

The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

21 January 2018

1 reference

NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27831

1 reference

13 December 2017

1 reference